Long Term Safety and Effectiveness of Tumour Necrosis Factor Inhibitors In Systemic Sclerosis Patients with Arthritis

被引：0
|
作者：
Omair, Mohammed [1 ]
Phumethum, Veerapong [2 ]
Johnson, Sindhu R. [3 ]
机构：
[1] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[2] Prapokklao Hosp, Chanthaburi, Thailand
[3] Toronto Western Hosp, Toronto, ON M5T 2S8, Canada
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1476
引用
收藏
页码：S577 / S577
页数：1
相关论文
共 50 条
  • [1] Long-term safety and effectiveness of tumour necrosis factor inhibitors in systemic sclerosis patients with inflammatory arthritis
    Omair, M. A.
    Phumethum, V.
    Johnson, S. R.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (02) : S55 - S59
  • [2] Effectiveness and safety of the treatment with tumour necrosis factor a antagonists in rheumatoid arthritis patients
    Mendoza, MA
    Aznárez, HN
    Hernández, MJR
    Ruiz, FJM
    [J]. MEDICINA CLINICA, 2005, 125 (01): : 35 - 36
  • [3] PREDICTING SUCCESSFUL LONG-TERM TREATMENT WITH TUMOUR NECROSIS FACTOR ALPHA INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS
    Fagerli, Karen M.
    Watson, Kath D.
    Packham, Jon
    Symmons, Deborah P. M.
    Hyrich, Kimme L.
    [J]. RHEUMATOLOGY, 2015, 54 : 134 - 135
  • [4] EFFICACY AND SAFETY OF TUMOUR NECROSIS FACTOR ALPHA INHIBITORS IN RHEUMATOID ARTHRITIS
    Baraza Cristina, Gomez
    Francisco Javier, Manero Ruiz
    Espasol Angela, Pecondon
    Mendoza Mercedes, Arenere
    Orbis Iciar, Casiamares
    Maria Jose, Rabanaque Hernandez
    [J]. ATENCION FARMACEUTICA, 2013, 15 (03): : 150 - 157
  • [5] Secondary loss of effectiveness among rheumatoid arthritis patients treated with tumour necrosis factor inhibitors
    Aaltonen, K.
    Isomaki, P.
    Joensuu, J.
    Sokka, T.
    Peltomaa, R.
    Piril, L.
    Varjolahti-Lehtinen, T.
    Uutela, T.
    Malmi, T.
    Ekman, P.
    Kononoff, A.
    Eklund, K.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2017, 46 (05) : 419 - 420
  • [6] TUMOUR NECROSIS FACTOR INHIBITORS PERSISTENCE IN PSORIATIC ARTHRITIS PATIENTS
    Vieira-Sousa, E.
    Eusebio, M.
    Avila-Ribeiro, P.
    Khmelinskii, N.
    Machado, A. R.
    Martins Rocha, T.
    Bernardes, M.
    Santos-Faria, D.
    Leite Silva, J.
    Santos, H.
    Miguel, C.
    Carvalho, P.
    Costa, T.
    Teixeira, L.
    Meirinhos, T.
    Nero, P.
    Santos, M. J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1584 - 1585
  • [7] Predicting Successful Long-Term Treatment with Tumour Necrosis Factor-Alpha Inhibitors in Patients with Psoriatic Arthritis
    Fagerli, Karen M.
    Watson, Kath D.
    Packham, Jonathon
    Symmons, Deborah P. M.
    Hyrich, Kimme L.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S679 - S680
  • [8] Tumour necrosis factor inhibitors: risks and benefits in patients with rheumatoid arthritis
    Roberts, L
    McColl, GJ
    [J]. INTERNAL MEDICINE JOURNAL, 2004, 34 (12) : 687 - 693
  • [9] Cancer risk and tumour necrosis factor inhibitors in patients with inflammatory arthritis
    Marino, Francesca
    Nucera, Valeria
    Gerratana, Elisabetta
    Fiorenza, Alessia
    Sangari, Donatella
    Miceli, Gianfranco
    Masala, Ignazio Francesco
    Atzeni, Fabiola
    [J]. PHARMACOLOGICAL RESEARCH, 2020, 158
  • [10] Immunogenicity of tumour necrosis factor inhibitors in patients with psoriasis receiving long-term treatment
    Meyer, M. W.
    Zachariae, C.
    Bendtzen, K.
    Skov, L.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (06) : E17 - E17
12345